SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF)

The QualityStocks Daily Newsletter would like to spotlight SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF).

This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising.

SPARC AI (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) is featured in an AINewsWire (“AINW”) editorial examining how widespread GPS jamming and spoofing across global conflict zones are undermining traditional navigation systems and accelerating demand for next-generation defense technologies, with the report noting the growing vulnerability of drone and precision-guided operations in contested environments. SPARC AI’s Overwatch platform is positioned as a software-based solution designed for GPS-denied conditions, enabling drones to navigate and identify targets without hardware modifications and offering a scalable, rapidly deployable alternative to more complex, hardware-dependent systems.

To view the full press release, visit https://ibn.fm/G1OaB

SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) develops next-generation, GPS-free target acquisition system and autonomous navigation software for drones and edge devices. Its zero-signature technology delivers real-time detection, tracking, and behavioral insights without reliance on radar, lidar, or heavy sensors. The company’s platform transforms unmanned systems into autonomous tools capable of identifying and engaging targets in GPS-denied environments.

The company’s vision is to redefine situational awareness by merging advanced mathematics, AI modeling, and edge computing into a unified intelligence architecture. SPARC AI aims to empower defense, rescue, and commercial organizations to operate safely and effectively in signal-contested environments where traditional navigation systems fail.

Its mission is to build the world’s most trusted geolocation intelligence platform that operates without GPS, enabling seamless interoperability across air, land, and sea devices.

SPARC AI is headquartered in Toronto, Canada.

Technology

SPARC AI’s technology suite delivers precision target acquisition, navigation, and autonomous intelligence in environments where GPS and traditional sensors fail. At its core is the Target Acquisition System, a software-only solution that determines the geolocation of any visible object using camera telemetry data. By removing the need for specialized hardware like lasers, radar, or lidar, the platform reduces weight, power use, and cost. Built on advanced mathematical modeling, it constructs a 3D understanding of terrain and position, achieving GPS-level accuracy in a zero-signature configuration suited for defense, rescue, and commercial operations.

SPARC AI Mobile extends this capability to handheld and field-issued devices, allowing operators to mark and transmit target coordinates directly from smartphones or rugged tablets. Once a target is identified, the device relays the coordinates to a connected drone, which autonomously navigates to the location for reconnaissance or engagement. The mobile system maintains accuracy even in GPS-jammed or degraded environments, turning each device into a connected node within a broader distributed network.

The company’s GPS-Denied Navigation engine enables mission planning and execution without satellite signals. Operators can design flight paths, define perimeters, and simulate routes to identify optimal vantage points and minimize resource use. Counter-surveillance and threat-prediction tools model adversarial visibility, helping users avoid detection and maximize ground coverage. Together, these capabilities form the foundation of SPARC AI’s software architecture, providing the intelligence backbone for its integrated command platform.

Overwatch Target Intelligence

Overwatch unifies all SPARC AI technologies, including its Target Acquisition, Mobile, and Navigation systems, into a single mission-ready platform that fuses detection, classification, tracking, and navigation in real time. It transforms drones and robotic systems into fully autonomous intelligence assets by synchronizing data across connected devices. The platform’s zero-signature design ensures complete operational security, allowing defense and rescue teams to conduct surveillance, reconnaissance, and engagement without GPS or active sensors.

Within Overwatch, the ATLAS Visibility Intelligence Engine enhances mission planning and reconnaissance through 2D and 3D visualization. Users can simulate line-of-sight coverage from any altitude, identify unseen or occluded areas, and optimize routes for surveillance or search and rescue. Operating entirely through software, ATLAS produces high-fidelity visibility data without mapping drones or additional power consumption, providing a lightweight, silent, and sensor-free alternative to lidar-based systems.

The SPARC AI SDK and open API framework extend Overwatch’s interoperability. Developers can embed SPARC AI’s intelligence into third-party systems such as PX4- and ArduPilot-powered drones, the world’s most widely used open-source flight platforms. The SDK provides REST APIs with bindings for Python, C++, and JavaScript and supports hardware including NVIDIA Jetson, Qualcomm Robotics RB5, and Raspberry Pi. Through these integrations, Overwatch serves as the command and intelligence layer of SPARC AI’s ecosystem, linking distributed drones, sensors, and edge devices into a coordinated autonomous network that operates entirely without GPS.

Market Opportunity

SPARC AI operates within the rapidly expanding defense, security, and commercial drone markets projected to exceed $100 billion over the next decade. The company’s software-defined approach addresses the global demand for autonomous systems capable of performing in denied, degraded, intermittent, and limited (DDIL) environments, positioning SPARC AI at the forefront of next-generation geolocation and targeting solutions.

Fortune Business Insights projects the global commercial drone market will reach approximately $65.25 billion by 2032, while Grand View Research estimates the combined drone hardware and services market will grow to $163.6 billion by 2030. With its per-device subscription model and integration across drones and robotic systems, SPARC AI is structured to capture recurring revenue from this accelerating adoption of GPS-denied intelligence technologies.

Leadership Team

Anoosh Manzoori, CEO, brings extensive experience as a technology entrepreneur, investor, and director, having founded, scaled, and exited multiple high-tech companies. He has taken five companies public, served on seven public company boards, and invested in innovations spanning cloud, fintech, biotech, IoT, defense, and AI.

Justin Hanka, Director, is an investment banking professional with 25 years of experience in mergers and acquisitions and capital markets. He has held executive roles at high-growth companies including iSelect.com.au and Helpmechoose, achieving multiple successful exits.

Anthony Haberfield, Director, is an international financial services executive with 30 years of experience across the Asia Pacific region, specializing in strategy, transformation, procurement, and emerging technology.

SPARC AI Inc. (OTCQB: SPAIF), closed Tuesday's trading session at $3.1983, up 24.4475%, on 457,308 volume. The average volume for the last 3 months is 83,790 and the stock's 52-week low/high is $0.0792/$3.46.

Recent News

• SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) - AINewsBreaks - SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) Featured In AINewsWire Coverage on Rising Demand for GPS-Denied Defense Technologies
• TechMediaBreaks - SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) Targets Growth in Defense Sector with Strategic Appointment
• SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) Advances Ukraine Defense Initiatives as Electronic Warfare Reshapes Battlefield

MAX Power Mining Corp. (CSE: MAXX) (OTC: MAXXF)

The QualityStocks Daily Newsletter would like to spotlight MAX Power Mining Corp. (CSE: MAXX) (OTC: MAXXF).

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising.

MAX Power Mining (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) announced that shareholders approved all resolutions at its Annual General and Special Meeting held April 17, 2026, including the appointment of Tony Van Burgsteden to the board of directors. A total of 31,363,104 common shares, representing approximately 24.8% of outstanding shares, were voted in person and by proxy, supporting the reappointment of D&H Group LLP as auditors, setting the board at six directors, electing six nominees, and approving the company’s shareholder rights plan. The company also granted 200,000 stock options and 200,000 RSUs to a director under its existing equity incentive plan.

To view the full press release, visit https://ibn.fm/JMepc

MAX Power Mining (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) reported preliminary results from a 3D seismic survey at its Lawson Natural Hydrogen system in Saskatchewan, delineating a large structural closure covering approximately 14.2 square kilometers and establishing a newly defined “Lawson Central” area that significantly expands the original discovery. The survey also identified multiple high-priority drill targets and outlined a broader “Lawson Complex” spanning roughly 28 square kilometers, supporting the potential for multiple producing wells with hydrogen and helium concentrations, as the company advances toward further drilling and evaluation of the system’s commercial potential.

To view the full press release, visit https://ibn.fm/o1sEG

MAX Power Mining Corp. (CSE: MAXX) (OTC: MAXXF) is a Canadian mineral exploration company pioneering the development of natural hydrogen as a potential new primary energy source. As a first mover in this emerging sector, the company has assembled North America’s largest permitted land package targeting naturally occurring, emissions-free hydrogen accumulations in the earth’s subsurface.

MAX Power plans to commence Canada’s first dedicated deep drilling program for natural hydrogen in November 2025, starting on the 200-km-long Genesis Trend in southern Saskatchewan, with the goal of converting a discovery into the world’s first commercial natural hydrogen venture in 2026.

Backed by institutional partnerships and a highly experienced technical team, MAX Power continues to build a globally recognized brand in the natural hydrogen sector. Its massive land package in Saskatchewan currently comprises 1.3 million permitted acres with another 5.7 million acres under application.

Saskatchewan, a jurisdiction recognized for its supportive regulatory environment and clean energy innovation, features North America’s most advanced policy framework for the exploration and development of natural hydrogen. The province is also known for its spectacular resource endowment as the world’s leading potash provider, the top high-grade uranium producer in the world, and Canada’s second-largest oil producer. Saskatchewan is also Canada’s leader in helium production, geothermal energy and carbon capture.

The company’s head offices are in Saskatchewan’s two largest cities, Saskatoon and Regina.

Projects

Natural Hydrogen (Saskatchewan)

MAX Power holds multiple large land packages across Saskatchewan prospective for deposits of natural hydrogen, highlighted by the 200-km-long Genesis Trend and the 75-km-wide Grasslands Project.

Genesis features easy road, rail and power access and a proposed hydrogen hub on its eastern side where there is an abundance of potential end-users for natural hydrogen. Drilling is set to begin in early November 2025 at the Lawson target situated in the heart of Genesis. Canada’s first deep well for natural hydrogen is specifically designed to test a complete five-element hydrogen system interpreted to exist at Lawson: source rocks, migration pathways, reservoirs, seals, and traps. Data from vintage and proprietary 2D seismic, gravity and magnetic surveys, and subsurface mapping, among other geological and geophysical information, support the prospectivity of Lawson which lies adjacent to an extensive regional “Salt Barrier” offering excellent seal and trap conditions.

The Genesis Trend’s scalability is further demonstrated by the recent identification of the Lucky Lake target, approximately 50 km northwest of Lawson and one of at least 20 Lawson “look-a-likes” that is being investigated along the trend. Early interpretation suggests serpentinized rocks and structural features favorable for hydrogen generation exist at Lucky Lake.

At Grasslands, geologists are excited about a broad area in the vicinity of a well (“Climax”) near the U.S. border that was drilled a few years ago and inadvertently resulted in Canada’s first known deep subsurface occurrence of natural hydrogen, associated with a rare rock assemblage geologists refer to as “exotic terrane”. Permits covering an area stretching 75 km east-west and up to 10 km north-south were acquired by MAX Power next to this discovery, amplifying the company’s first-mover advantage. Adjacent to three sides of Grasslands are producing helium wells owned by privately-held North American Helium, demonstrating that this under-explored area of the province is highly prospective for clean gas. Drilling of a target at Grasslands is expected during Q1 2026.

Other MAX Power land packages are Rider 1, 2 and 3 in the southeast part of the province, and Choiceland in the north-central part of the province.

To enhance scientific rigor and accelerate development, MAX Power has established a multi-year strategic collaboration with the Petroleum Technology Research Centre (PTRC), a globally recognized leader in subsurface energy research based in Regina, Saskatchewan. This partnership complements the company’s relocation to Innovation Saskatchewan’s R+T Parks in Saskatoon and Regina, placing its technical and executive teams at the heart of the province’s academic, regulatory, and infrastructure ecosystem.

Critical Minerals

MAX Power’s other key asset is its Wilcox Lithium Project in mining-friendly Cochise County in southeast Arizona where first-ever diamond drilling in late 2023/early 2024 confirmed the discovery of near-surface lithium-rich clays over a broad area of the Willcox Playa. MAX Power’s property occurs within a nearly 4,000-acre corridor adjacent to U.S. Department of Defense land, and benefits from direct access through roads, rail and power infrastructure. The discovery was made just as lithium entered its final price downturn and is now being intensely revisited by the company in light of the turnaround in lithium and an emphasis on critical mineral resource development in the United States under the Trump administration.

Market Opportunity

According to company materials, the global hydrogen market is valued at approximately $250 billion and is expected to surpass $400 billion by 2030. Supporting this outlook, a study published in Science Advances (Dec. 2024) estimates that in-place natural hydrogen resources could meet global net-zero carbon goals for roughly 200 years. Closer to home, a feasibility study by the Transition Accelerator (April 2024) projects that the Regina-Moose Jaw Industrial Corridor (RMJIC) in Saskatchewan could support a C$708 million annual hydrogen market, with province-wide demand reaching as high as C$2.7 billion per year.

These projections underscore a compelling opportunity to establish a new energy economy centered around natural hydrogen—a low-cost, low-emission, and potentially naturally replenishing resource. MAX Power is well-positioned to lead this effort with proximity to infrastructure, favorable geology, and increasing institutional support.

Leadership Team

Mansoor Jan, CEO, brings more than two decades of international experience across mining operations, capital markets, and business development. He has held senior positions at BHP Australia, BHP Chile, and Rio Tinto, where he was responsible for advancing cross-border projects, driving mine optimization, and leading technology delivery across major jurisdictions. Mr. Jan holds a BA and MSc in Economics and a Master of Commerce from the University of New South Wales in Australia.

Neil McMillan, Director and Chair of the Audit Committee, is the former Chairman of the Board of Cameco, the world’s largest publicly traded uranium company. Mr. McMillan served on Cameco’s board for 16 years and is highly regarded within and outside the province for his decades of success there. He previously led Claude Resources as President and CEO, paving the way for its development into Saskatchewan’s only profitable gold miner which was bought out for more than $300 million by Silver Standard Resources in 2014.

Steve Halabura, Chief Geoscientist, has decades of successful experience in the province’s resource sector including a deep understanding of the geological controls on the accumulation of hydrogen, helium, and other industrial gases. He was also instrumental in the early formative stages of the only two Saskatchewan greenfield potash mines to come into existence in the 21st century, these being BHP’s Jansen Project and K+S’s Bethune mine. Jansen is the largest private investment ($14 billion) in Saskatchewan history and is located northeast of MAX Power’s Genesis Trend.

Tom Kishchuk, MAX Power’s Senior Strategic Advisor for Natural Hydrogen Development, is CEO for the Saskatchewan-based Global Institute for Energy, Mines and Society (GIEMS). He has over three decades of technical and business leadership in national and global organizations focused on the energy sector.

MAX Power Mining Corp. (OTC: MAXXF), closed Tuesday's trading session at $1.03, up 0.9803922%, on 135,434 volume. The average volume for the last 3 months is 342,020 and the stock's 52-week low/high is $0.124/$1.3.

Recent News

• MAX Power Mining Corp. (CSE: MAXX) (OTC: MAXXF) - MiningNewsBreaks - MAX Power Mining Corp. (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) Expands Lawson Discovery With 3D Seismic Results
• InvestorNewsBreaks - MAX Power Mining Corp. (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) Reports Shareholder Approval of All Resolutions and Board Appointment
• Renewables on the Rise in the US Despite Opposition from Trump

Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF)

The QualityStocks Daily Newsletter would like to spotlight Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF).

Disseminated on behalf of Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) and may include paid advertising.

Exploration companies such as Powermax Minerals (CSE: PMAX) (OTCQB: PWMXF) are advancing REE projects in Canada and the United States, all of which are in a position to benefit from growing geopolitical pressures. A recent article discussing this reads, “The push to diversify rare earth supply is gaining momentum. Policymakers in the United States and Canada have begun directing public funding toward domestic mining and processing capacity, including grants and long-term procurement commitments tied to national security. The urgency of that effort has grown as tensions rise between Washington and Beijing over trade, technology and geopolitical alignment. If China further restricts rare earth exports, particularly in response to global conflicts or sanctions, the ripple effects could hit sectors ranging from semiconductor manufacturing to aerospace.”

To view the full article, visit https://ibn.fm/Ow2Pt

Disseminated on behalf of Powermax Minerals Inc., may include paid advertisements.

Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) is a Canadian mineral exploration company developing a portfolio of rare earth element (“REE”) projects across Tier-1 jurisdictions in Canada and the United States. Focused on discovery, responsible advancement, and alignment with North America’s critical-minerals strategy, the company targets areas with geological potential for REE-bearing pegmatites and granitic systems.

Its exploration model emphasizes modern geophysics, data integration, and systematic de-risking through technical work. By concentrating on projects with clear infrastructure advantages and policy support, Powermax seeks to contribute meaningfully to regional supply-chain independence in critical minerals vital to electrification and advanced manufacturing.

The company’s growing asset base includes four core REE projects, Atikokan, Cameron, Pinard and Ogden Bear Lodge, positioned within highly prospective geological corridors.

Powermax Minerals is headquartered in Toronto, Ontario.

Projects

Atikokan REE Project – Northwestern Ontario

Powermax’s flagship Atikokan Rare Earth Element Project covers 9,416 hectares across three mineral claim blocks (A, B, and C) approximately 35 kilometers northwest of the town of Atikokan in the Thunder Bay Mining District. Located along the White Otter–Dashwa corridor, the project hosts REE-enriched granitic and pegmatitic systems supported by strong radiometric and geochemical signatures.

In 2025, Powermax completed airborne magnetic and gamma-ray spectrometric surveys, geological mapping, and geochemical sampling. An integrated interpretation released in November 2025 outlined a structural–geochemical corridor of REE enrichment, with Total Rare Earth Element (TREE) values from 254 ppm to 1,947 ppm across Blocks B and C. The company is currently advancing surface validation and target ranking for follow-up work.

Cameron REE Project – British Columbia

The Cameron Project, which the company holds an option to acquire, is located about 30 kilometers south of Revelstoke in the Kamloops Mining Division and comprises three contiguous mineral claims totaling 2,984 hectares.

Hosted within the Monashee Group, the property contains NYF-type granitic pegmatites and gneissic units known to carry both light and heavy REEs. Phase 1 exploration, completed under NI 43-101 recommendations, produced TREE values ranging from 17 ppm to 1,943 ppm, with heavy mineral concentrate samples up to 7,561 ppm. These findings confirmed consistent REE enrichment and led to the launch of Phase 2 exploration in October 2025 to expand mapping and refine drill targets.

Ogden Bear Lodge REE Project – Wyoming, USA

Powermax owns a 100% interest in the Ogden Bear Lodge Project, covering 22 lode claims (184 hectares) in Crook County, Wyoming. The property is prospective for high-grade neodymium-praseodymium (Nd/Pr) oxide mineralization and shares a border with Rare Element Resources’ Bear Lodge Critical Rare Earth Project. That neighboring project has received $24.2 million in U.S. Department of Energy support and a non-binding EXIM Bank letter of interest for up to $553 million in debt financing, highlighting the strategic value of this emerging U.S. REE district.

Pinard Rare Earths Project – Northern Ontario

In November 2025, Powermax Minerals announced plans to acquire a 100% interest in the Pinard Rare Earths Project, located roughly 70 kilometers north-northeast of Kapuskasing, Ontario. The property consists of 255 contiguous claims totaling 5,178 hectares within the Pinard Intrusive Rock Complex, an alkaline igneous system characterized by nepheline syenites and peralkaline granites commonly associated with REE-bearing mineralization.

Market Opportunity

Global demand for rare earth elements is projected to triple—from 59,000 tonnes in 2022 to 176,000 tonnes by 2035—driven by rapid electric-vehicle adoption and wind-power expansion, with supply expected to lag by up to 30%. The global REE market, valued at $3.95 billion in 2024, is forecast to reach $6.3 billion by 2030 at a compound annual growth rate of approximately 8.6%, according to Grand View Research.

China currently controls approximately 60% of REE mining and about 90% of processing capacity, prompting North American governments to accelerate domestic development. In 2025, the U.S. Department of Energy announced $1 billion in critical-minerals funding opportunities, while Canada’s C$1.5 billion Critical Minerals Infrastructure Fund supports projects through 2030. Together, this policy support and structural supply deficit highlight Powermax’s positioning within a strategically essential market tied to the clean-energy transition.

Leadership Team

Paul Gorman, CEO & Director, is a resource-based corporate specialist with more than 25 years of experience in junior mining finance, public listings, and corporate development. He is the President and Managing Partner of Riverbank Capital Inc., where he has raised over $150 million for emerging issuers and helped revitalize the North American graphite industry through the founding of Mega Graphite Inc. Gorman has led multiple exploration programs and was instrumental in achieving high-grade lithium discoveries in 2024 for Pan American Energy Corp.

Michael Malana, Director, has more than 20 years of international experience in financial management, reporting, and corporate governance. He has held senior executive roles across natural resources, biotechnology, and manufacturing and holds a Bachelor of Commerce degree from Concordia University in Montreal. Malana is a Chartered Professional Accountant (Certified Management Accountant).

Afzaal Pirzada, M.Sc., P.Geo., Director, is a professional geoscientist with over 30 years of experience in mineral exploration and mining, specializing in gold, lithium, graphite, rare metals, and uranium. He has served as Project Geologist, VP Exploration, Director, and CEO for multiple mining companies, including Adriana Resources and Rock Tech Lithium. Pirzada is a registered Professional Geoscientist with Engineers and Geoscientists British Columbia and has authored numerous NI 43-101 technical reports.

Powermax Minerals Inc. (OTCQB: PWMXF), closed Tuesday's trading session at $0.27483, up 19.4913%, on 48,441 volume. The average volume for the last 3 months is 102,870 and the stock's 52-week low/high is $0.22/$1.98.

Recent News

• Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) - RockBreaks - Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) Advances Amidst a New Critical Minerals Race
• Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) Key to Helping Address China's Stranglehold on Rare Earth Elements
• InvestorNewsBreaks - Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) Uncovers High-Value Rare Earth Trends in British Columbia

American Fusion Inc. (OTC: AMFN)

The QualityStocks Daily Newsletter would like to spotlight American Fusion Inc. (OTC: AMFN).

American Fusion (OTC: AMFN) is featured in AINewsWire editorial coverage examining how surging artificial intelligence adoption is driving unprecedented demand for electricity and reshaping global energy infrastructure priorities. The report underscores that hyperscale data centers and AI workloads are rapidly increasing power consumption, creating bottlenecks in aging grid systems and elevating energy availability as a critical constraint on future AI growth. American Fusion (OTC: AMFN) is advancing aneutronic fusion and related infrastructure strategies aimed at delivering scalable, high-efficiency power solutions aligned with next-generation compute demands, alongside industry leaders such as NVIDIA Corporation (NASDAQ: NVDA), Microsoft Corporation (NASDAQ: MSFT), Amazon.com Inc. (NASDAQ: AMZN) and Constellation Energy Corporation (NASDAQ: CEG). The company’s focus reflects a broader sector shift from research-driven innovation to execution-focused deployment as energy capacity becomes central to sustaining AI-driven economic expansion.

To view the full press release, visit https://ibn.fm/3P3UN

American Fusion Inc. (OTC: AMFN) is an advanced energy platform company focused on building a scalable, infrastructure-grade fusion energy business through its wholly owned subsidiary, Kepler Fusion Technologies. Following a completed reverse merger with Kepler, the company has repositioned itself around the development and long-term commercialization of deployable fusion power systems designed for real-world industrial and infrastructure use rather than experimental research programs.

The company’s strategy centers on pairing proprietary fusion technology with disciplined governance, intellectual property development, and a public-company operating framework intended to support long-duration value creation. Management has emphasized transparency, regulatory readiness, and institutional credibility as foundational elements alongside continued technical progress.

The company is based in Southlake, Texas.

Kepler Texatron™

Through wholly owned subsidiary, Kepler Fusion Technologies, the company is developing the Texatron™ aneutronic fusion platform, a compact, pulsed fusion system engineered specifically for commercial and infrastructure-grade deployment. Unlike steady-state fusion concepts that prioritize laboratory demonstration, the Texatron™ operates in controlled cycles designed to support modular scalability, redundancy, and distributed installation across multiple end markets.

The platform is optimized around a Deuterium–Helium-3 fuel pathway that enables direct electrical energy conversion, reducing reliance on traditional steam cycles and minimizing neutron-related material degradation. This design supports a smaller physical footprint and greater flexibility for deployment in grid-constrained or mission-critical environments such as data centers, industrial facilities, defense installations, and remote locations.

Kepler’s commercialization model is structured around a Power-as-a-Service approach under which the company intends to retain ownership of its fusion units and sell electricity to customers under long-term contractual arrangements. This infrastructure-oriented model is designed to align system deployment with predictable, recurring revenue while allowing for fleet-based scaling over time. The platform is supported by a broad and expanding intellectual property estate encompassing reactor architecture, energy conversion systems, control technologies, manufacturing processes, and deployment methodologies.

Market Opportunity

U.S. electricity demand has re-entered a period of sustained growth following nearly two decades of relative stagnation, according to data from the U.S. Energy Information Administration. After years in which efficiency gains and structural economic shifts largely offset population and economic growth, electricity consumption has increased meaningfully since 2020 and is forecast to continue rising through at least the middle of the decade.

Recent and projected growth is being driven primarily by the commercial and industrial sectors, with data centers, advanced manufacturing, and other power-intensive operations accounting for a disproportionate share of incremental demand. These segments tend to require continuous, non-intermittent electricity supply, placing increased pressure on existing generation and transmission infrastructure.

This shift underscores a growing need for reliable baseload power sources that can be deployed without extensive new transmission build-out and that align with emissions-reduction objectives. Fusion-based energy systems designed for distributed, infrastructure-grade deployment represent a potential long-term solution for meeting rising demand in environments where reliability, resilience, and scalability are critical.

Leadership Team

Richard Hawkins, Chairman and Chief Executive Officer, has overseen the company’s strategic reset, corporate restructuring, and transition toward an advanced fusion energy platform, with responsibility for governance, capital markets strategy, and long-term corporate development.

Brent Nelson, Chief Executive Officer of Kepler Fusion Technologies, brings extensive experience in energy systems and commercialization strategy and leads the development, validation, and deployment roadmap for the Texatron™ fusion platform, as well as Kepler’s intellectual property and operating model.

American Fusion Inc. (OTC: AMFN), closed Tuesday's trading session at $0.05275, up 14.6739%, on 7,722,207 volume. The average volume for the last 3 months is 7,852,590 and the stock's 52-week low/high is $0.000001/$0.08.

Recent News

• American Fusion Inc. (OTC: AMFN) - AINewsBreaks - American Fusion Inc. (OTC: AMFN) Positioned At Nexus Of AI Power Demand As AINewsWire Highlights Energy Constraint Theme
• American Fusion(TM) Inc. (AMFN) Expands Strategic Positioning at ARPA-E Energy Innovation Summit
• GreenEnergyBreaks - American Fusion Inc. (OTC: AMFN)?Appoints Samuel Reid as Government Strategy and Procurement Advisor

Oncotelic Therapeutics Inc. (OTCQB: OTLC)

The QualityStocks Daily Newsletter would like to spotlight Oncotelic Therapeutics Inc. (OTCQB: OTLC).

Oncotelic Therapeutics (OTCQB: OTLC) was highlighted in a BioMedWire editorial examining how advancing drug pipelines are increasingly being recognized as measurable financial assets under U.S. GAAP, reflecting a broader shift in biotech valuation. The company was noted for leveraging its diversified pipeline and strategic holdings, including a 45% stake in GMP Bio, recently valued at more than $1 billion, as an example of how scientific progress and proximity to commercialization can directly enhance balance sheet value and investor perception.

To view the full press release, visit https://ibn.fm/DPVZ8

Oncotelic Therapeutics Inc. (OTCQB: OTLC) is a clinical-stage biopharmaceutical company developing RNA-based, immunotherapy, and targeted therapeutics for cancer and other underserved diseases. The company is focused on transforming outcomes for patients with difficult-to-treat and rare conditions, particularly pediatric cancers and aggressive solid tumors. Its development strategy centers on novel compound design, nanoparticle drug delivery, and the integration of artificial intelligence to accelerate discovery and regulatory workflows.

At the center of this foundation is Chairman and CEO Dr. Vuong Trieu, a prolific industry pioneer who has filed more than 500 patents with 75 issued patents across biologics, small molecules, nanoparticles, and diagnostics. Dr. Trieu co-invented Abraxane® (sold to Celgene for $2.9 billion), underscoring his track record of creating high-value therapies. Through collaborations with industry leaders and its stake in specialized joint ventures, Oncotelic is positioned to advance a diverse portfolio of oncology assets with greater speed and cost efficiency. The company also operates a proprietary AI platform, PDAOAI, which streamlines scientific writing, regulatory documentation, and data interpretation. This system is accessible to the public through a dedicated Discord server, offering real-time engagement with Oncotelic’s research ecosystem.

With expanded clinical activity and a next-generation development model, Oncotelic continues to evolve as a multi-asset innovator in precision oncology.

The company is headquartered in Agoura Hills, California.

Pipeline and Partnerships

Oncotelic’s lead candidate is OT-101, currently in a Phase 3 trial for pancreatic ductal adenocarcinoma (STOP-PC study) and evaluated in gliomas and metastatic solid tumors in combination with IL-2 and checkpoint inhibitors. The antisense molecule targets TGF-β2, a cytokine known to suppress immune responses and promote tumor growth. A Phase 1 trial combining OT-101 with IL-2 was recently completed, demonstrating safety and paving the way for combination therapies with PD-1 blockers and other immunotherapies.

Recent data have further strengthened the rationale for OT-101 in pancreatic ductal adenocarcinoma (PDAC). In June and July 2025, two peer-reviewed studies published in the International Journal of Molecular Sciences identified TGF-β2 gene expression and methylation status as significant prognostic markers in PDAC, particularly among younger patients and those with low CD8+ T-cell infiltration. High TGF-β2 expression correlated with reduced overall survival, while elevated TGF-β2 methylation was associated with improved outcomes. These findings validate TGF-β2 as a high-priority target and support the continued development of OT-101 as a precision therapy. Both studies leveraged Oncotelic’s proprietary AI-driven platform, PDAOAI, to mine and assemble multi-omic datasets, showcasing the system’s role in accelerating insight generation.

The company holds a 45% ownership stake in GMP Biotechnology Limited, a joint venture with Dragon Capital Overseas Limited. GMP Bio owns SAPU Bioscience, which is executing several pipeline programs. SAPU and Oncotelic are jointly utilizing a rapid IND platform through their partnership with Shanghai Medicilon to support regulatory filings for up to 20 drug candidates, with five INDs already underway. This collaboration is central to accelerating development of next-generation anticancer agents.

After the joint venture, Dr. Trieu, with his team, built out a state of the art and GMP-certified R&D facility in San Diego, which operates under SAPU, that manufactures clinical trial materials and supports a proprietary nanoparticle platform trademarked Deciparticle ™. This platform includes four therapeutic candidates—two of which are in late-stage manufacturing and expected to enter IND filing before the end of 2025.

Additionally, Oncotelic owns AL-101, an intranasal administered apomorphine product intended for the treatment of Parkinson’s disease, Erectile Dysfunction, and Female Sexual Disorders.

Market Opportunity

Oncotelic is targeting large and underserved therapeutic markets with significant commercial potentials. The global pancreatic cancer treatment market alone is projected to grow at a 12.3% CAGR, reaching $5.84 billion by 2030, up from $2.92 billion in 2024, according to Research and Markets. This growth is driven by increased disease prevalence, aging populations, and demand for more effective treatment options. Notably, the incidence of early-onset PDAC is rising at an estimated rate of 4% per year in the 15–34 age group, highlighting an emerging unmet need for targeted therapies among younger patients.

Beyond oncology, Oncotelic intends to develop AL-101 for Parkinson’s disease, which affects over 1 million patients in the U.S. alone and is expected to impact 1.2 million by 2030. Erectile Dysfunction and Female Sexual Dysfunction are also major global health issues, with Erectile Dysfunction affecting up to 70% of men over 60 and Female Sexual Dysfunction impacting approximately 40% of women—both with limited treatment options, particularly for patients who fail to respond to existing medications. These underserved populations offer fertile ground for innovative new therapies.

Leadership Team

Dr. Vuong Trieu is the Chairman and CEO of Oncotelic Inc. An accomplished innovator in pharmaceutical development, Dr. Trieu previously served as President and CEO of Igdrasol, where he pioneered the approval path for paclitaxel nanomedicine via a single bioequivalence trial. After Igdrasol merged with Sorrento Therapeutics, he became Chief Scientific Officer and a Board Director. He also held leadership roles at Cenomed, Abraxis, Applied Molecular Evolution, and Parker Hughes Institute. Dr. Trieu holds a Ph.D. in Molecular Microbiology, a B.S. in Botany, has published widely, and filed over 500 patent applications with 75 issued U.S. patents.

Amit Shah is the Chief Financial Officer of Oncotelic Inc. He has over 20 years of financial leadership in life sciences, including CFO roles at Marina Biotech and Igdrasol, and senior positions at ISTA Pharmaceuticals, Spectrum Pharmaceuticals, and Caraco. He also worked in consulting and ERP implementation. Mr. Shah holds a Bachelor of Commerce from the University of Mumbai, is an Associate Chartered Accountant in India, and is an inactive CPA in Colorado.

Dr. Anthony E. Maida III is the Chief Clinical Officer – Translational Medicine at Oncotelic Inc. He has over 25 years of experience advancing cancer immunotherapies and held senior roles at Northwest Biotherapeutics, PharmaNet, and Jenner Biotherapies. He has raised over $200 million for biotech firms and negotiated licensing deals with institutions such as Pfizer, Eli Lilly, and Yale. Dr. Maida holds dual B.A. degrees in Biology and History, an MBA, an M.A. in Toxicology, and a Ph.D. in Immunology, and is active in ASCO, AACR, and other scientific societies.

Oncotelic Therapeutics Inc. (OTCQB: OTLC), closed Tuesday's trading session at $0.0389, up 3.0737%, on 84,750 volume. The average volume for the last 3 months is 283,590 and the stock's 52-week low/high is $0.015/$0.11.

Recent News

• Oncotelic Therapeutics Inc. (OTCQB: OTLC) - BioMedNewsBreaks - Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in BioMedWire Editorial on Biotech Valuation Trends
• BioMedNewsBreaks - Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in BioMedWire Editorial Highlighting Biotech's Shift Toward Science-Driven Asset Valuation
• Oncotelic Therapeutics Inc. (OTLC) Expands Beyond Biotech Through AI-Robotics Pivot, Unlocking New Value in GMP Automation

Planet Ventures Inc. (CSE: PXI) (OTC: PNXPF)

The QualityStocks Daily Newsletter would like to spotlight Planet Ventures Inc. (CSE: PXI) (OTCQB: PNXPF).

Disseminated on behalf of Planet Ventures Inc., may include paid advertisements.

This article has been disseminated on behalf of Planet Ventures Inc. and may include paid advertising.

Planet Ventures (CSE: PXI) (OTC Pink: PNXPF) (FSE: P6U) announced it has engaged Independent Trading Group to provide market-making services in accordance with Canadian Securities Exchange policies, with the objective of improving liquidity and maintaining an orderly market for its common shares. Under the agreement, ITG will receive CAD$6,000 per month, paid in advance, for an initial one-month term beginning April 21, 2026, with automatic monthly renewals unless terminated with 30 days’ notice; no shares or options will be issued as compensation, and the parties are unaffiliated.

To view the full press release, visit https://ibn.fm/KfERh

Planet Ventures Inc. (CSE: PXI) (OTC: PNXPF) is an investment issuer focused on identifying and investing in innovative companies operating within the space and aerospace sectors. The company’s strategy is centered on providing shareholders with exposure to emerging, high-growth opportunities, including private companies that are typically accessible primarily to venture capital and institutional investors.

The company employs a portfolio-driven investment approach, seeking to build a diversified base of investments across multiple segments of the space economy. Its activities are focused on sourcing and participating in opportunities globally, leveraging its network and experience to access and evaluate potential investments aligned with long-term growth trends in the sector.

Planet Ventures aims to create shareholder value through strategic capital allocation into companies developing technologies and services that support the expanding commercial space ecosystem.

The company is headquartered in Vancouver, British Columbia.

Portfolio

Planet Ventures operates as an investment platform, deploying capital into companies across the space and aerospace value chain, including infrastructure, software, energy, robotics, and emerging applications.

The company’s investment thesis is based on the view that many of the most significant opportunities in the space sector remain private and are not directly accessible to public market investors. Through its investment approach, Planet Ventures provides shareholders with indirect exposure to these companies, including through positions that may offer access to private businesses typically only available to venture capital and institutional investors.

Launch & Infrastructure

Planet Ventures has gained exposure to Relativity Space Inc. through an investment in MCXGP Relativity Fund I LLC, a special purpose vehicle that participated in the company’s most recent financing round. Relativity Space is developing reusable launch vehicles, including the Terran R rocket, designed for mid-to-heavy lift missions and low Earth orbit satellite deployment.

The company has also invested in Mantis Space Corp., which is developing orbital energy infrastructure intended to deliver power to satellites and other space-based systems.

Software & Data Platforms

Planet Ventures has made a strategic investment in Antaris Inc., an AI-powered platform designed to support the design, simulation, and operation of satellite constellations. The platform is intended to streamline mission development and enable software-driven approaches to space operations.

Emerging Applications & Robotics

Planet Ventures has invested in Galactic Resource Utilization Space Inc. (GRU Space), a company focused on developing habitat infrastructure for use beyond Earth, including concepts related to space tourism.

The company has also invested in General Astronautics, a space robotics company developing autonomous systems designed to operate in microgravity environments to support research and manufacturing activities in space.

Market Opportunity

Planet Ventures operates within the global space economy, which is valued at approximately $626 billion in 2025 and is projected to exceed $1.8 trillion by 2035, according to data from the World Economic Forum. Growth in the sector is being driven by increasing commercialization (with commercial revenues accounting for 78% of the total market, according to the Space Foundation), as well as expanding satellite applications, infrastructure development, and national security initiatives.

The space economy encompasses a wide range of activities that can be broadly divided into upstream and downstream segments. Upstream activities include launch systems, satellite manufacturing, and on-orbit operations, while downstream activities include satellite communications, navigation and positioning services, and earth observation.

The satellite segment represents a significant portion of the overall market, alongside growing areas such as space infrastructure, software platforms, and emerging commercial applications. Increased participation from private companies continues to play a central role in the expansion of the sector.

Leadership Team

Etienne Moshevich, Chief Executive Officer, has a background in capital markets and private investing and has focused on evaluating, financing, and advising early-stage and growth companies across multiple sectors. His role includes portfolio strategy, capital allocation, and investor relations, with a focus on aligning management teams and shareholders toward long-term outcomes.

Desmond Balakrishnan, Executive Director, is a partner at McMillan LLP and an experienced capital markets and securities lawyer. He has advised clients across multiple industries and has experience in private equity investments, public offerings, mergers and acquisitions, and listed company advisory.

Brian Shin, Chief Financial Officer, specializes in financial reporting, corporate finance, auditing, corporate strategy, and risk management. He provides accounting and consulting services to both public and private companies and has served as CFO for multiple organizations in Canada.

Planet Ventures Inc. (OTCQB: PNXPF), closed Tuesday's trading session at $0.2489, even for the day. The average volume for the last 3 months is 201,930 and the stock's 52-week low/high is $0.0274/$0.5.

Recent News

• Planet Ventures Inc. (CSE: PXI) (OTC: PNXPF) - InvestorNewsBreaks - Planet Ventures Inc. (CSE: PXI) (OTC Pink: PNXPF) (FSE: P6U) Engages ITG for Market-Making Services
• InvestorNewsBreaks - Planet Ventures Inc. (CSE: PXI) (OTC Pink: PNXPF) (FSE: P6U) Adopts Disclosure Policy And Updates Investment Strategy
• InvestorNewsBreaks - Planet Ventures Inc. (CSE: PXI) (OTC Pink: PNXPF) (FSE: P6U) Invests in Relativity Space Financing Round

Numa Numa Resources Inc.

The QualityStocks Daily Newsletter would like to spotlight Numa Numa Resources Inc.

The closure of the Strait of Hormuz, alongside China’s decision to halt exports of sulfuric acid from May 1, is tightening global supplies of a critical chemical used in copper production. The combined effect is placing mounting pressure on both the agricultural and mining industries, which depend heavily on acid-intensive processes. Chile, a major hub for copper production and the largest importer of sulfuric acid, is particularly vulnerable to rising costs. At the same time, prolonged geopolitical tensions between Iran and the United States, including a blockade targeting Iranian ports, are extending supply chain disruptions. Some mining operations are better insulated. Projects that produce sulfuric acid internally as a by-product are less exposed to import disruptions. Others are implementing contingency measures, including securing fuel supplies, to maintain operations amid ongoing uncertainty. These developments come as diplomatic disagreements between Iran and the U.S. remain unresolved after recent talks failed to produce a way forward. In response, the U.S. imposed a blockade affecting vessels linked to Iranian ports, further restricting traffic through the already strained Strait of Hormuz. As acid supply constraints play out, mine development companies like Numa Numa Resources Inc. are likely to pick up lessons and plan how to guard against operational disruptions of this nature in the future. 

Numa Numa Resources Inc. is a mining and infrastructure development company focused on unlocking transformational opportunities in the Autonomous Region of Bougainville, where the company is headquartered and where its management has lived and worked for 10 years.

Bougainville, a resource-rich archipelago in the South Pacific, is perhaps best known as the home of the Panguna Mine. Developed by Rio Tinto, the Panguna Mine was the largest open cut copper and gold mine in the world when it operated from 1972 to 1989 before being shuttered due to a civil war, called “the Crisis,” between Bougainville and its parent government Papua New Guinea. In 2001, the Bougainville Peace Agreement ended the war and awarded Bougainville limited autonomy, including its own constitution, by which ownership of the mine reverted to its customary landowners. A majority of the Panguna Mine’s copper, gold, and silver ore resources remain within its walls, making the fully explored and developed Panguna Mine one of the largest ore bodies in the world, today worth approximately $100 billion. Most geologists who have studied Bougainville believe that other nearby locations such as Mainoki and Karato are highly prospective and may contain ore deposits similar in size and scale to those of the Panguna Mine.

Numa Numa’s fundamental strength is the relationships it has developed over the years with the landowners in the Panguna, Mainoki, and Karato resource areas.

Pursuant to newly executed written agreements, Numa Numa has formed and now owns a stake in three new corporate entities that will own and develop, with the Panguna, Mainoki, and Karato landowners, their respective resources as partners pursuant to the laws and regulations of Bougainville. One entity has been established for Panguna, one for Mainoki, and one for Karato. Each entity is co-owned with the landowners of those respective areas. Each owns all the landowners’ resource rights to that area, and each entity is to be managed by a joint company/landowner team led by Numa Numa. Due to Bougainville’s constitution and law, each of these entities therefore effectively controls the monetization of the resources in its area. In Bougainville, the landowners—not the government—own the resources. With the Panguna, Mainoki, and Karato landowners as its contractual partners, Numa Numa now expects to prosper significantly in its mining endeavors in Bougainville.

Numa Numa has a contractual agreement to develop the Panguna Mine executed both with the Panguna Mine Landowner Clan Chiefs—the governmentally accepted owners of the Panguna Mine—and the government of Bougainville and President Ishmael Toroama, along with its rights to the exploration licenses regarding Mainoki and Karato for which it has applied and is awaiting approval. The company will be pursuing all such rights through those corporate entities. Numa Numa, together with its landowner partners, fully expect that these entities will ultimately be issued licenses and approvals by the government to legally pursue mining activities in their respective areas. Together with the Panguna, Mainoki, and Karato landowners, Numa Numa then intends to partner with mining companies who are now being invited to explore, fully develop, and ultimately construct and operate these prime Bougainville mining opportunities.

These new assets distinguish Numa Numa from any other aspirants in Bougainville. No one has any similar entities or relationships with any landowners, even in non-prospective areas, and certainly nothing in Panguna, Mainoki, and Karato, described as the three most important mining areas of Bougainville. That said, Numa Numa also continues to develop a road system in Bougainville’s roadless mining region, a limestone quarry and calcination facility to supply lime to all of Bougainville’s mining operations, and an integrated electric utility to supply electricity to Bougainville.

Metals Market Opportunity

The Panguna Mine contains one of the world’s largest copper and gold ore bodies, but the size of the mine’s resource is only one of its favorable characteristics. The amount of resources in the Panguna Mine are beyond dispute. The mine’s reserves are proven, while most of the world’s major deposits waiting to be mined are not. The Panguna Mine itself is highly accessible and comes with developed infrastructure; much of the roads, port facilities, and other infrastructure built to service the Panguna Mine remain largely intact.

The Panguna Mine’s two most important metals—gold and copper—are, at current market prices, almost equally valuable. Together, the mine’s proven gold and copper resources underscore its role as a global tier-one asset.

Panguna’s 547.15 metric tons of known gold reserves equate to nearly 1% of all global reserves, with value estimates exceeding $40 billion. Given the growing interest by many nations in denominating their trade balances in something other than U.S. dollars, the price of gold has increased dramatically over the last two years, and no end is in sight.

As for copper, the global transition to electrification is triggering historic demand for it, yet the supply pipeline is critically constrained. According to RBC Dominion Securities, just four new large-scale copper mines are in development globally, while demand requires at least one new mine per year through 2035. The Panguna Mine’s copper reserves total 5.3 million metric tons—equal to roughly 70% of Canada’s total reserves—placing it in the same league as major copper-producing nations. With ore grades declining and permitting delays mounting worldwide, the Panguna Mine—let alone Mainoki and Karato when they are explored—is uniquely positioned to help fill the world’s looming copper supply gap.

Independence Requires Numa Numa Rebuilding the Panguna Mine—and Diplomacy

Bougainville is currently an autonomous region of Papua New Guinea, but the 2001 Bougainville Peace Agreement provided Bougainville with the right, within 20 years, to conduct an independence referendum. During this period, Bougainville’s current president, Ishmael Toroama, was the lead proponent in advocating Bougainvillean independence. In 2019, the independence referendum, in which registered Bougainvilleans were asked whether they wished to remain part of Papua New Guinea or become citizens of a new, independent country, was held, and 97.7% of the population chose independence. The next year, Ishmael Toroama was elected President of Bougainville.

Numa Numa assisted Toroama in both his independence initiatives and his presidential election. Both Numa Numa and President Toroama, as well as the great majority of Bougainvilleans, understand that Bougainvillean independence depends on having the means to pay for its cost.

Simply put, Bougainvillean independence depends on rebuilding the Panguna Mine. Bougainvilleans know that they cannot do it themselves. The people understand that, and identify Numa Numa’s business plan for rebuilding the Panguna Mine, as well as the support they assume will come from its Western affiliations—most of the company’s shareholders are either American or Canadian—as the key to not only their prosperity, but their freedom as well.

Bougainvilleans also back Numa Numa’s business plan because they fear the alternative: China, which covets not only Bougainville’s gold and copper, but its strategic location together with its deepwater port at Loloho, the best deepwater port in the Third Island Chain.

On the front line in the Western Pacific’s rising tensions between China and the U.S., Bougainvilleans far prefer an alliance with their tradition Western allies to a takeover by China. Numa Numa’s ongoing diplomatic engagement, including arranging recent visits to Washington D.C. with President Ishmael Toroama, positions the company as both an economic and strategic partner in shaping Bougainville’s future.

Leadership Team

John D. Kuhns, Chairman & Chief Executive Officer, founded Numa Numa Resources and has led the company since its formation in 2016. He previously founded China Hydroelectric Corporation, the largest foreign-owned electric power company in China, and listed the company on the NYSE. He has taken five other infrastructure and energy companies from initial concept to public listings and has owned and managed three Wall Street investment firms. He holds degrees from Georgetown University, the University of Chicago, and Harvard Business School and is also the author of four published novels.

Shadron L. Stastney, Vice-Chairman & Chief Operating Officer, joined Numa Numa Resources as a consultant in 2022 and became its Vice-Chairman and Chief Operating Officer in 2025. He was previously the co-founder of Vicis Capital, a multi-strategy hedge fund with peak assets of $6.8 billion. Before that, he was a Director and Head of the Hedging and Monetization Group at Credit Suisse First Boston, and a corporate attorney at Cravath, Swaine and Moore. He received his JD from Yale Law School and his BA from the University of North Dakota.

Anthony Dixon, Director, founded and was the CEO of Helios Renewable Energy Limited, a solar energy developer, and Metanoia, a sustainability auditor. He is also the Founder and Chairman of The Alliance for Sustainable Schools. His previous roles include CEO of ASB Biodiesel, Senior Advisor for Project Development in Asia with Canadian Solar; a Director of China Hydroelectric Corporation; Chief Operating Officer of ZEDFactory; and a Director of the Solar Electric Light Company. He was a Managing Director and Head of UK Capital Markets with Citigroup Global Markets; a Vice President with Salomon Brothers; and Director of Nikko Salomon Smith Barney in Tokyo, where he co-headed the firms’ securitization business. He holds a first-class honors degree in physics and a B.A. in philosophy from the University of Western Australia, an MBA from Harvard Business School, and a master’s degree in renewable energy engineering from Imperial College, London.

Mary E. Fellows, Director, has more than two decades of experience in renewable energy and infrastructure development. She previously served as EVP, Chief Compliance Officer, and Corporate Secretary of China Hydroelectric Corporation, and held leadership roles at GenSelf Corporation, Solar Electric Light Company, and New World Power Corporation. She holds a bachelor’s degree from Teikyo Post University and is a graduate of Harvard Business School’s AMP program.

Ian Smith, Director, is a mining engineering honors graduate from the University of Queensland, Australia. He has 60 years’ experience in the international mining industry, spanning functions including corporate management, operations, project management and engineering. Significantly, he was involved with the development of Bougainville’s Panguna copper-gold mine, from exploration, pre-production and startup to full production. The Panguna Mine at the time was the largest open pit copper-gold mine in the world. He was mine manager until he took another corporate responsibility in Mexico to develop the 72,000tpd La Caridad open pit copper mine. Additional operations and engineering experience include the 2,500 tpd CIL gold project in Uruguay and mining projects in Asia, South America, Africa, and the Pacific Rim.

Lawrence Queen, Senior Consulting Geologist, has over 35 years of experience in global mineral exploration, including five years as Principal Economic Geologist for the Geological Survey of Papua New Guinea. He holds a BSc from the New Mexico Institute of Mining and Technology and an MSc from the University of Alaska and is a long-standing member of both the Australasian Institute of Mining and Metallurgy and the Australian Institute of Geoscientists.

Tete Omas, Manager, Lakeville Mines, oversees operations at Numa Numa’s mining subsidiary and brings deep, hands-on experience in gold mining and equipment fabrication. A second-generation miner, he previously served in the PNG Mineral Resource Authority’s Small Scale Mining Branch and began his career working on his family’s mining lease at Mt. Kaindi.

Seeking Investors: Intention to Go Public Soon

Numa Numa is seeking investors—strategic and financial—to be partners in its world-class, resource-rich Bougainville opportunity. The company’s goal is to not only be the leading mining entity in Bougainville, but to become the country’s leading commercial enterprise as well.

Numa Numa is currently a privately held corporation but is exploring means of going public so as to list its shares on one or more international stock exchanges and provide its shareholders with liquidity.

Recent News

• Numa Numa Resources Inc. - Hormuz Closure Disrupts Copper Output as Acid Supply Tightens
• Iran War Disrupts Chemical Supply for DRC’s Cobalt and Copper Miners
• Debate Rages on Viability of Proposed Copper Smelter in B.C.

Forward Industries Inc. (NASDAQ: FWDI)

The QualityStocks Daily Newsletter would like to spotlight Forward Industries Inc. (NASDAQ: FWDI).

• The crypto market as a whole goes through many ups and downs, and the current prices provide a unique opportunity for investors to buy low.
• In addition to investors taking advantages of prices, companies see a chance to manage their own shares, such as Forward Industries, a company building and managing a large-scale Solana treasury.
• Specifically, Forward Industries recently entered into an agreement to repurchase shares from an institutional investor.

Solana and the rest of the crypto market has gone through many ups and downs over the last few years. The current volatility and pressures in the market, encouraged by ongoing geopolitical factors, have led to attractive entry prices for those looking to get involved with crypto. Current prices, along with growing concern about the future of the USD and other fiat currencies, provide a unique buy-low opportunity for investors who either missed out on getting in on crypto before, or are looking to increase their investment in the space.

In addition to individual investors taking advantage of the current prices, some companies in the space, such as Forward Industries Inc. (NASDAQ: FWDI) have entered into repurchase agreements. Forward Industries builds, operates, and manages a large-scale Solana (SOL) treasury, and is backed by many of the most influential investors in the digital space. Recently, the company announced a strategic share repurchase where it bought back over 6 million common shares of its common stock from an institutional investor (https://ibn.fm/WbISU), for a total price of $27.4 million.

Forward Industries Inc. (NASDAQ: FWDI) is building and managing a large-scale Solana (SOL) treasury, backed by some of the most influential investors in the digital asset space. The company’s strategy centers on long-term shareholder value through active participation in the Solana ecosystem, which it views as uniquely positioned to underpin future global capital markets due to its high throughput, deep economic activity, and growing developer adoption.

Through this shift, Forward Industries aims to create value by accumulating SOL and strategically deploying assets through on-chain opportunities including staking, lending, and participation in decentralized finance (DeFi). Forward also became the first U.S.-listed company to bring its common stock onto the Solana blockchain, reinforcing its focus on digital-native capital markets.

Forward Industries is headquartered in New York.

Solana Treasury Operations

In September 2025, Forward Industries closed a $1.65 billion private investment in public equity (PIPE) led by Multicoin Capital, Galaxy Digital, and Jump Crypto. The PIPE proceeds were deployed to acquire over 6.8 million SOL at an average price of $232 per token, with a portion executed on-chain via DFlow, a decentralized exchange aggregator built exclusively for Solana trading applications. The company has since staked the entirety of its treasury, actively generating yield through native Solana infrastructure and DeFi applications.

Forward’s strategy is centered on growing SOL per share, leveraging a range of tools including at-the-market (ATM) equity offerings and potential preferred equity issuance. The company is also targeting acquisitions and strategic partnerships within the Solana ecosystem to accelerate treasury yield and ecosystem alignment. As part of its infrastructure expansion, Forward tokenized its FORD shares on the Solana blockchain in collaboration with Superstate and plans to acquire an equity interest in the platform. The tokenized shares are expected to enable 24/7 trading, real-time settlement, and eligibility for use as DeFi collateral.

This shift was supported by the company’s board and executive team, whose composition reflects deep alignment with the Solana ecosystem — including leadership from Multicoin Capital and board observers from Galaxy and Jump Crypto. The company’s stated objective is to establish itself as the leading institutional participant in the Solana ecosystem, uniquely positioned to capture both economic yield and strategic exposure to one of the fastest-growing blockchain networks in the world.

Market Opportunity

Solana has emerged as the most performant blockchain in the digital asset space, processing over 8.9 billion transactions in Q2 2025 and sustaining approximately $3 billion in daily decentralized exchange (DEX) trading volume. Year to date, Solana applications have generated over $4 billion in fees and more than $1 billion in real economic value (REV), a proxy for free cash flow generated by the network.

DeFi participation, stablecoin usage, and developer activity have all grown substantially, with over $1.5 trillion in swap volume recorded through 2025. SOL staking yields have averaged over 8%, comprised of both inflationary rewards and organic yield from network activity. With 17 pending ETF applications and major institutions like BlackRock, Visa, PayPal, and HSBC integrating Solana, Forward Industries is positioned to benefit from a rising tide of institutional adoption, tokenization of real-world assets, and increased demand for high-performance blockchain infrastructure.

Leadership Team

Kyle Samani, Chairman of Forward Industries, is the co-founder and Managing Partner of Multicoin Capital, an early Solana backer and one of the largest holders of SOL. Samani contributed $25 million to the PIPE and is a key strategic leader behind Forward’s treasury roadmap.

Mike Pruitt, Interim CEO of Forward Industries, joined the board in February 2025 and was appointed Interim CEO in May. He is the founder of Avenel Financial Group and previously served as CEO of Chanticleer Holdings, bringing decades of public company leadership and capital markets experience.

Kathleen Weisberg, Chief Financial Officer of Forward Industries, was appointed CFO in July 2023 after serving as Corporate Controller since 2020. Weisberg is a CPA with prior roles at WW International, Symbol Technologies, and Ernst & Young.

Forward Industries Inc. (NASDAQ: FWDI), closed Tuesday's trading session at $4.68, off by 3.9014%, on 602,469 volume. The average volume for the last 3 months is 865,715 and the stock's 52-week low/high is $4.03/$46.

Recent News

• Forward Industries Inc. (NASDAQ: FWDI) - Current Solana and Cryptocurrency Prices Seen as Opportunity to Buy Low Amidst Ongoing Concerns About Debt and Fiat Currencies
• MissionIRNewsBreaks - Forward Industries, Inc. (NASDAQ: FWDI) Appoints Mark Brazier as Chief Financial Officer
• InvestorNewsBreaks - Forward Industries Inc. (NASDAQ: FWDI) Delivers Strong Results as Solana Treasury Expands

CNS Pharmaceuticals Inc. (NASDAQ: CNSP)

The QualityStocks Daily Newsletter would like to spotlight CNS Pharmaceuticals Inc. (NASDAQ: CNSP).

Primary and metastatic central nervous system (CNS) tumors can have extraordinary biological and anatomical complexity, and these tumors can be hard to identify using traditional imaging or histopathology analysis. Molecular analysis has emerged as a major way to identify these tumors and help medical teams plan how best to help those diagnosed with these cancers. Biomarker testing is a growing field that is making it possible for the molecular structure of CNS cancers to be analyzed for not only diagnostic purposes but also other functions as well. Recent advances like the detection of tumor RNA particles in blood samples now mean that a brain cancer can be identified and tracked without subjecting patients to surgical procedures to get a tumor sample. Biomarker testing also makes it possible for patients to access therapies that could save their lives or extend their survival. For instance, new treatments that target particular genetic mutations behind some cancers are emerging. When molecular tests are done and confirm that a patient’s CNS cancer is linked to a particular mutation, such as the H3 K27M oncogenic mutation in DMG (diffuse midline glioma), such a patient can be put on available therapies targeting that mutation. Consequently, the survival of the patient can be extended and the progress of the cancer could be slowed down. As companies like CNS Pharmaceuticals Inc. (NASDAQ: CNSP) advance their drug development efforts with a focus on central nervous system cancers, greater awareness of biomarker testing by the medical community and patients may be a huge step in matching these emerging treatments with the patients who need them the most. 

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) is a clinical stage biotechnology company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system.

The company was founded in 2017 and is headquartered in Houston, Texas.

Organ Targeted Therapeutics

The company’s lead drug candidate, Berubicin, is proposed for the treatment of glioblastoma multiforme (“GBM”), an aggressive and incurable form of brain cancer. Berubicin also has potential to treat other central nervous system malignancies. Based on limited clinical data, Berubicin appears to be the first anthracycline to cross the blood brain barrier in the adult brain, and it was the subject of a successful Phase 1 study which found the MDT and produced efficacy data as well.

CNS holds a worldwide exclusive license to the Berubicin chemical compound. The company has acquired all requisite data and know-how from Reata Pharmaceuticals Inc. related to a completed Phase I clinical trial of Berubicin in malignant brain tumors. In this trial, 44% of patients experienced a statistically significant improvement in clinical benefit. In 2017, CNS entered into a collaboration and asset purchase agreement with Reata.

CNS intends to explore the potential of Berubicin to treat other diseases, including pancreatic and ovarian cancers and lymphoma. The company is also examining plans to develop combination therapies that include Berubicin.

CNS estimates that more than $25 million in private capital and grants were invested in Berubicin prior to the company’s $9.8 million IPO in November 2019.

CNS intends to submit an IND for Berubicin during the fourth quarter of 2020 and expects to commence a Phase II clinical trial of Berubicin for the treatment of GBM in the U.S. in Q1 2021. A sub-licensee partner was awarded a $6 million EU/Polish National Center for Research and Development grant to undertake a Phase II trial of Berubicin in adults and a first-ever Phase I trial in pediatric GBM patients in Poland in 2021.

The company’s second drug candidate, WP1244, is a novel DNA binding agent licensed from the MD Anderson Cancer Center. In preclinical studies, WP1244 proved to be 500-times more potent than the chemotherapeutic agent, daunorubicin, in inhibiting tumor cell proliferation. The company has entered into a sponsored research agreement with the MD Anderson Cancer Center to further the development of WP1244.

CNS Pharmaceuticals recently engaged U.S.-based Pharmaceutics International Inc. and Italian BSP Pharmaceuticals SpA for the production of the Berubicin drug product. The company has implemented a dual-track manufacturing strategy to mitigate COVID-19-related risks, diversify its supply chain and provide for localized availability of Berubicin. CNS has already completed synthesis of Berubicin’s active pharmaceutical ingredient (API) and has shipped the API to both manufacturers in order to prepare an injectable form of Berubicin for clinical use.

Global Brain Tumor Therapeutics Market

The high recurrence rate of malignant brain tumors is due to reappearance of focal masses, indicating that a sub-population of tumor cells in these cancers may be insensitive to current therapies and may be responsible for reinitiating tumor growth. This necessitates the development of newer drugs in the market that demonstrate greater efficacy in treating such aggressive cancers.

A global increase in neurological disorders has placed increased attention on cancers of the brain over the past decade. Neurological disorders are becoming one of the most prevalent types of disorders, due to longer life expectancy, greater exposure to infection and an increasingly sedentary lifestyle. Because few treatments for primary and metastatic cancers of the brain exist, costs are high and have acted as a restraint for the brain tumor therapeutics market.

Despite progress in surgery, radiotherapy and chemotherapeutic strategies, effective treatments for brain cancer are limited by a lack of specific therapies for the brain and the difficulty in transporting therapeutic compounds across the blood brain barrier. Therefore, there is a significant need for novel and effective therapeutic drugs and strategies that prolong survival and improve quality of life for brain tumor patients.

Several companies are making significant investments into R&D, which is expected to bring more treatment options to the market in the near future. Industry reports consistently project continued growth in the market.

One report estimates that the global brain tumor therapeutics market will reach a valuation of $2.74 billion in 2023, with the market expected to register a CAGR of 11% during the forecast period from 2018 to 2023. Another report projects that the global brain tumor therapeutics market will reach $3.4 billion by 2025, up from $2.25 billion in 2019 (https://nnw.fm/eDUjp).

Management Team

John M. Climaco is the CEO of CNS Pharmaceuticals. For 15 years, Climaco has served in leadership roles for a variety of health care companies. Recently, Climaco served as the Executive Vice President of Perma-Fix Medical S.A, where he managed the development of a novel method to produce Technitium-99. Climaco also served as President and CEO of Axial Biotech Inc., a DNA diagnostics company. In the process of taking Axial from inception to product development to commercialization, Climaco forged strategic partnerships with Medtronic, Johnson & Johnson and Smith & Nephew.

Christopher Downs, CPA, is the company’s Chief Financial Officer. Downs previously served as Interim Chief Financial Officer and Executive Vice President of InfuSystem Holdings Inc. (NYSE: INFU), a supplier of infusion services to oncologists in the United States. Downs holds a Bachelor of Science from the United States Military Academy at West Point, an MBA from Columbia Business School and a Master of Science in Accounting from the University of Houston-Clear Lake.

Dr. Donald Picker is the Chief Scientific Officer of CNS. Picker has over 35 years of drug development experience. Prior to joining CNS, Picker worked at Johnson Matthey, where he was responsible for the development of Carboplatin, one of the world’s leading cancer drugs, which was acquired by Bristol-Myers Squibb with annual sales of over $500 million. In addition, he oversaw the development of Satraplatin and Picoplatin, third-generation platinum drugs currently in late-stage clinical development.

Sandra L. Silberman, M.D., Ph.D., is the Chief Medical Officer of CNS Pharmaceuticals. Silberman is a hematologist/oncologist who earned her B.A., Sc.M. and Ph.D. from the Johns Hopkins University School of Arts and Sciences, School of Public Health and School of Medicine, respectively, and her M.D. from Cornell University Medical College. She then completed both a clinical fellowship in hematology/oncology and a research fellowship in tumor immunology at the Brigham & Women’s Hospital and the Dana Farber Cancer Institute in Boston, Massachusetts. Silberman has played key roles in the development of many drugs, including Gleevec(TM), for which she led the global clinical development at Novartis. Silberman advanced several original, proprietary compounds into Phases I through III during her work with leading biopharmaceutical companies, including Bristol-Myers Squibb, AstraZeneca, Imclone and Roche.

CNS Pharmaceuticals Inc. (NASDAQ: CNSP), closed Tuesday's trading session at $2.46, off by 8.5502%, on 36,846 volume. The average volume for the last 3 months is 35,758 and the stock's 52-week low/high is $2.0573/$34.7988.

Recent News

• CNS Pharmaceuticals Inc. (NASDAQ: CNSP) - Why Molecular Testing is Increasingly Important in CNS Cancers
• Scientists Discover Brain Cells That Aid Brain Cancer Development
• Preclinical Study Reveals Promising Treatment for Glioblastoma

Soligenix Inc. (NASDAQ: SNGX)

The QualityStocks Daily Newsletter would like to spotlight Soligenix Inc. (NASDAQ: SNGX).

Dr. Christopher J. Schaber outlines strategies for navigating constrained funding environment

Soligenix (NASDAQ: SNGX) CEO Dr. Christopher J. Schaber emphasized the importance of capital discipline in a Pharmaphorum analysis examining how biotech companies can succeed in today’s constrained funding environment, where even late-stage programs may struggle to secure investment. The article notes that strong science alone is no longer sufficient, with companies needing to align capital, execution and development strategy to achieve value-defining milestones that attract continued funding. The analysis describes capital discipline as an operating philosophy focused on directing resources toward key inflection points where data reduces uncertainty and increases program value, while also stressing the need to design development plans around fundable milestones and maintain realistic, resilient budgets. It further highlights the role of prioritization, partnerships and non-dilutive funding, noting that disciplined execution is especially critical in higher-risk areas such as rare disease development. Schaber concludes that companies best positioned to endure are those that integrate scientific innovation with disciplined financial and operational execution, building investor confidence and advancing programs efficiently toward commercialization.

Soligenix Inc. (NASDAQ: SNGX) is a late-stage biopharmaceutical company focused on developing and commercializing treatments for rare diseases with high unmet medical needs. Operating through two key segments, the company’s Specialized BioTherapeutics division is dedicated to oncology and inflammation therapies, while its Public Health Solutions segment advances vaccines and therapeutics targeting biothreats and infectious diseases.

The company is actively advancing multiple late-stage clinical programs, including HyBryte™ (SGX301), a novel photodynamic therapy for cutaneous T-cell lymphoma (CTCL). Additional candidates in development target psoriasis (SGX302), oral mucositis (SGX942), and Behçet’s disease (SGX945), while its public health efforts focus on heat-stable vaccines for ricin poisoning (RiVax®), Ebola (SuVax™), and Marburg (MarVax™) viruses, that have been supported by non-dilutive government grants and contracts of approximately $60 million to date.

With a diversified pipeline, multiple orphan and fast-track designations, and collaborations with government agencies, Soligenix is uniquely positioned for potential regulatory approvals and commercialization.

The company is headquartered in Princeton, New Jersey.

Pipeline and Development Programs

Specialized BioTherapeutics

Soligenix’s Specialized BioTherapeutics division develops treatments for oncology and inflammatory diseases, focusing on conditions with few or no effective therapeutic options. HyBryte™ (synthetic hypericin) has completed a Phase 3 study for CTCL, demonstrating statistically significant efficacy, and a second confirmatory Phase 3 trial is actively enrolling patients to support potential regulatory submissions worldwide. If approved, it would be the first non-mutagenic photodynamic therapy for early-stage CTCL, addressing an unmet medical need. It has received orphan drug designations in the U.S. and Europe, as well as Fast Track designation in the U.S.

SGX302, a photodynamic therapy based on the same active ingredient as HyBryte™, is in clinical development for mild-to-moderate psoriasis, with positive Phase 1/2 proof-of-concept results, it is actively enrolling patients in a Phase 2a clinical trial.

SGX942, designed to reduce inflammation and tissue damage in oral mucositis associated with cancer treatment, is progressing as a potential first-in-class therapy.
SGX945, targeting aphthous ulcers in Behçet’s disease, is actively enrolling in a Phase 2a clinical trial and has received fast-track designation, highlighting the urgency of developing effective treatments for this rare inflammatory condition.

Public Health Solutions

The company’s Public Health Solutions segment focuses on medical countermeasures for biothreats and emerging infectious diseases, leveraging non-dilutive government funding to advance its programs. RiVax®, a ricin toxin vaccine, has demonstrated strong preclinical and early clinical results and may be eligible for government procurement under the Strategic National Stockpile initiative.

The company’s RiVax®, as well as its vaccine candidates for Ebola and Marburg viruses are based on its proprietary ThermoVax® technology, which stabilizes vaccines for long-term storage without refrigeration. This approach could be transformative in regions where maintaining cold-chain logistics is challenging.

The ongoing development of these vaccines is supported by funding from NIH, BARDA, and DTRA, with the potential for up to three priority review vouchers (PRVs) upon regulatory approval, to be used for future programs or sold. Notably, PRVs have previously sold for roughly $100 million.

Market Opportunity

Soligenix targets markets with significant commercial potential, focusing on rare diseases and biodefense applications. HyBryte™ addresses CTCL, a disease affecting over 68,000 patients across the U.S. and Europe, with a total market opportunity exceeding $250 million. SGX302, the company’s therapy for mild-to-moderate psoriasis, serves a much larger population, as over eight million people in the U.S. are affected by the condition, representing a global market opportunity exceeding $1 billion.

SGX942, developed for oral mucositis in head and neck cancer patients, is aimed at a market worth more than $500 million, while SGX945 for Behçet’s disease serves a niche segment valued at over $200 million worldwide.

In addition to its rare disease programs, Soligenix’s Public Health Solutions division has the potential to generate significant revenue through government procurement contracts. By focusing on both orphan drug markets and government-funded biodefense initiatives, Soligenix has positioned itself for sustained revenue growth through multiple high-value opportunities.

Leadership Team

Christopher J. Schaber, PhD, Chairman, President & CEO, brings to the company more than 35 years of experience in the biopharmaceutical industry. Before joining Soligenix, he held senior and operational leadership roles at Discovery Laboratories, Acute Therapeutics, Ohmeda Pharmaceuticals, The Liposome Company, and Wyeth Ayerst Laboratories. He has extensive expertise in drug development, regulatory affairs, and corporate strategy, positioning him to drive Soligenix’s growth and advancement toward commercialization.

Richard Straube, MD, Chief Medical Officer, has more than 35 years of experience in drug development and clinical research. Prior to joining Soligenix, he held key leadership roles at Stealth Peptides, INO Therapeutics, Ohmeda Pharmaceuticals, and Centocor. Throughout his career, he has played a crucial role in bringing innovative therapies to market, particularly in inflammatory diseases and immunology, making him a valuable asset in advancing Soligenix’s late-stage clinical programs.

Oreola Donini, PhD, Chief Scientific Officer, has more than 20 years of experience in pharmaceutical research and development, with expertise in immunology, inflammation, and rare diseases. Before joining Soligenix, she held leadership positions at Inimex Pharmaceuticals, ESSA Pharma, and Kinetek Pharmaceuticals, where she worked on novel drug discovery and translational medicine. Her experience in preclinical research and product development supports Soligenix’s continued innovation in biopharmaceuticals.

Jonathan Guarino, CPA, CGMA, Chief Financial Officer, has over 25 years of experience in corporate finance and strategic financial planning. Before joining Soligenix, he held financial leadership positions at Hepion Pharmaceuticals, Covance, BlackRock, and Barnes & Noble. His expertise in financial management, accounting, and capital markets plays a critical role in Soligenix’s financial strategy and operational efficiency.

Soligenix Inc. (NASDAQ: SNGX), closed Tuesday's trading session at $1.34, off by 2.8986%, on 313,445 volume. The average volume for the last 3 months is 356,537 and the stock's 52-week low/high is $1/$6.2299.

Recent News

• Soligenix Inc. (NASDAQ: SNGX) - BioMedNewsBreaks - Soligenix Inc. (NASDAQ: SNGX) CEO Highlights Capital Discipline as Critical to Biotech Success in Pharmaphorum Analysis
• BioMedNewsBreaks - Soligenix Inc. (NASDAQ: SNGX) Highlights Patient-Centric Drug Development Strategy Through Reformulation Approach
• Soligenix Inc. (NASDAQ: SNGX) Strengthens Pipeline as European Commission Grants SGX945 Orphan Status

Massimo Group (NASDAQ: MAMO)

The QualityStocks Daily Newsletter would like to spotlight Massimo Group (NASDAQ: MAMO).

Massimo Group (NASDAQ: MAMO) , operating through its Massimo Motor division, today announced continued expansion of its electric vehicle fleet across municipal, commercial and institutional markets, alongside development of its second-generation autonomous patrol golf cart platform. The company is deploying vehicles across site-based environments including public safety, property management, campuses and industrial facilities, reflecting rising demand for durable, cost-efficient solutions for recurring use. In parallel, Massimo is advancing a next-generation platform designed with integrated autonomous patrol capabilities, continuous monitoring and real-time communication functionality, enabling extended operations and direct data transmission to personnel, with potential applications across manufacturing, commercial properties, campuses, parks and logistics sites.

To view the full press release, visit https://ibn.fm/2kluX

Electric vehicles have broken free of the oil price cycle that governed their previous adoption waves. While earlier sales surges typically collapsed when energy prices fell and the underlying economic case evaporated, the current expansion rests on an entirely different foundation. The self-reinforcing economics of battery manufacturing have completely changed the economics of owning a battery electric vehicle (BEV). Battery storage costs have dropped by roughly 93% since 2010 as the production learning curve has compounded with every expansion of manufacturing scale. For every doubling of total output across the industry, unit costs have historically fallen by approximately 9%. Regions built around conventional vehicle production are facing significant workforce reductions. Historical transitions of comparable scale suggest those losses are not quickly reversed. Western EV plants in early production have needed more workers on the assembly floor than forecast. On the other hand, Chinese manufacturers run some facilities at automation levels high enough that interior lighting serves no purpose. The economic rewards and workforce displacements are not falling on the same regions or the same people. Addressing that gap will require deliberate policy, not just market momentum. As market momentum builds and allows firms like Massimo Group (NASDAQ: MAMO) to deepen their presence in the markets they serve, governments will have to come up with the necessary policies to move vehicle electrification to the next level. 

Massimo Group (NASDAQ: MAMO) is a prominent manufacturer and distributor specializing in powersports vehicles and recreational watercraft. Established in 2009, the company has built a reputation for delivering value-packed utility terrain vehicles (UTVs), all-terrain vehicles (ATVs), and on-road vehicles to both recreational enthusiasts and professionals in the agricultural sector. In 2020, Massimo expanded its offerings by launching Massimo Marine, dedicated to crafting high-quality watercraft with advanced designs and exceptional customer service.

Massimo Group is focused on sustainability. Its recent initiatives, including the introduction of the MVR Series of electric carts, highlight the company’s commitment to eco-friendly solutions that address growing consumer demand for sustainability in the powersports and marine industries.

The company’s manufacturing capabilities have also evolved significantly. Its expanded 376,000-square-foot facility in Garland, Texas, now features advanced automation, including a vehicle assembly robot line. This addition is expected to significantly enhanced production capacity and efficiency, enabling Massimo to scale its operations and better meet market demand.

Product Portfolio

Massimo Group’s product portfolio showcases its dedication to innovation and versatility. Its diverse lineup combines advanced features, sustainability, and value to meet the needs of a dynamic market.

• Massimo Motor: This category includes a wide range of UTVs, ATVs, go-karts, and mini-bikes designed for both recreational and practical applications. Notable recent additions include the T-Boss 1000 UTV, which combines rugged performance with advanced features, and the GKD 350 All-Terrain Go-Kart, a versatile two-seater ideal for various terrains. The Buck 550-6 Crew, a six-seater UTV, further expands this lineup, providing comfort and utility for families and light-duty users at an accessible price point.
• Massimo Marine: Specializing in pontoon and tritoon boats, this division emphasizes luxury and performance. A recent collaboration between Massimo and Vision Marine Technologies has introduced electric pontoon platforms, catering to consumers seeking eco-friendly watercraft for both commercial and recreational use.
• Massimo Electric: Reflecting the company’s commitment to sustainability, Massimo Electric focuses on low-speed electric vehicles (LSVs) tailored for diverse applications. Recent launches include the MVR 2X Golf Cart and MVR Cargo Max Utility Cart, which deliver advanced features and versatility for recreational users and professionals in industries like farming and groundskeeping.

By combining practicality with cutting-edge design, Massimo Group seeks to set the standard in the powersports and marine industries.

Market Opportunity

The global ATV and UTV market is experiencing robust growth, with North America projected to reach approximately $9.18 billion in 2024 and expand at a compound annual growth rate (CAGR) of 7.8% to $13.37 billion by 2029, according to Mordor Intelligence. Likewise, the U.S. electric UTV and ATV powertrain market is rapidly expanding. It was valued at $2.46 billion in 2022 and is expected to grow at a CAGR of 10.2%, reaching $5.18 billion by 2030, as reported by Grand View Research.

The pontoon boat market complements this growth, driven by increased interest in leisure and marine tourism. The market size exceeded $7.9 billion in 2022 and is projected to grow at a CAGR of 8.3% through 2032, according to Global Market Insights. Massimo Marine’s introduction of electric pontoon platforms through its Vision Marine partnership is expected to position the company to effectively address this growing market segment.

With strategic partnerships and an expanding dealer network, Massimo believes it is poised to penetrate deeper into domestic and international markets. The company’s service coverage currently includes over 2,800 retail locations, 600 motor service centers, and 5,500 marine service centers, ensuring robust support and accessibility for customers. This extensive distribution network underpins Massimo’s ability to capture market share and drive sustained growth.

Leadership Team

David Shan, Founder, Chairman, and CEO, established Massimo Motor in 2009 and Massimo Marine in 2020. He has led the company through significant growth phases, including the development of diverse product lines and its public listing. Shan holds a bachelor’s degree in international trade from Qingdao Ocean University of China.

Dr. Yunhao Chen, CPA, serves as the company’s Chief Financial Officer, bringing extensive experience in capital markets, financial reporting, and corporate governance since her appointment in May 2023. She holds a Ph.D. in Accounting and an MBA in Finance from the University of Minnesota.

Michael Smith, Vice President, joined Massimo in 2019 and played a pivotal role in launching Massimo Marine. With a strong background in powersports retail and product innovation, he is dedicated to driving new product development. Smith studied International Business and Marketing at the University of California, San Diego.

Massimo Group (NASDAQ: MAMO), closed Tuesday's trading session at $1.1, off by 3.5088%, on 434,362 volume. The average volume for the last 3 months is 2,644,297 and the stock's 52-week low/high is $0.85/$5.59.

Recent News

• Massimo Group (NASDAQ: MAMO) - InvestorNewsBreaks - Massimo Group (NASDAQ: MAMO) Expands Electric Fleet Network, Advances Autonomous Patrol Platform
• EVs Appear to Have Passed Their Tipping Point
• InvestorNewsBreaks - Massimo Group (NASDAQ: MAMO) Appoints Quenton Petersen as CEO, Transitions David Shan to Executive Chairman

ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF)

The QualityStocks Daily Newsletter would like to spotlight ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF).

This article has been disseminated on behalf of ESGold Corp. and may include paid advertising.

ESGold (CSE: ESAU) (OTCQB: ESAUF) was featured in the latest episode of IBN’s MiningNewsWire Podcast, where CEO Gordon Robb outlined the company’s strategy to achieve near-term production and internally fund exploration at its Montauban Gold-Silver Project in Quebec. Robb emphasized ESGold’s “tailings to cash” model, leveraging existing surface material to generate revenue while advancing exploration through modern technologies, with 2026 positioned as a key year as the company accelerates facility construction, launches its maiden drill program and targets concurrent production and exploration milestones.

To view the full press release, visit https://ibn.fm/wE4hM

ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) is a fully permitted, pre-production resource company on a clear path to near-term gold and silver production. With established infrastructure in place and a significant gold-silver resource, the company is uniquely positioned to generate near-term cash flow while unlocking the full potential of its Montauban Gold-Silver Project in Quebec—one of the top mining jurisdictions in the world.

ESGold is building a foundation for long-term growth through a dual-track strategy: cash-flow generation from tailings reprocessing to fund district-scale exploration.

The Montauban site, which operated as a mine for over 80 years, is now undergoing its first-ever systematic exploration program to determine just how large the remaining deposit may be. Near-term cash flow from tailings reprocessing will be used to fund exploration, with the goal of increasing the resource base and uncovering new discoveries across the expansive land package.

ESGold is advancing a scalable and replicable clean extraction model that turns legacy mine sites into revenue generating assets while setting a new industry benchmark for sustainable resource recovery.

The recent completion of a C$3.4M financing has enabled ESGold to initiate the final construction phase of its mill circuit—moving the company decisively toward production of gold and silver in Q3 2025.

Montauban Gold-Silver Project: Production Imminent

Located approximately 80 kilometers west of Quebec City, the Montauban Project is a past-producing gold-silver mine with surface and underground mineralization and over 900,000 tonnes of historical tailings. ESGold has invested over C$15 million to date, building out roads, power access, and a 16,000 sq. ft. processing facility. The company recently completed a C$3.4M financing to begin final construction of the mill circuit.

The company is fully permitted to enter into production that is expected to commence in Q3 2025 with a capacity of 500 tonnes per day, scaling to 1,000 tpd. An updated Preliminary Economic Assessment (PEA) is currently underway to reflect all-time high gold prices and the anticipated upside from the near-surface resource.

Parallels Between Broken Hill & Montauban

Broken Hill, discovered in 1883 in Australia, became the world’s largest source of silver, lead, and zinc—producing over $100 billion worth of metals. What made it unique was that the richest mineral zones were hidden deep underground in a twisted, boomerang-like shape, and it took decades to fully understand just how large the deposit really was.

Geologists now believe ESGold’s Montauban Project in Quebec may share similar traits. Like Broken Hill, it contains high-grade silver, lead, and zinc, along with gold—and sits within the same type of geological system known to host large, high-value mineral deposits. The rock formations, mineral assemblages, and structural complexity all suggest that Montauban could be hiding much more than what’s been historically uncovered. Academic studies now support this possible geological parallel, pointing to further evidence suggesting Montauban was formed under similar conditions as Broken Hill.

Exploration Upside

With production on the horizon, ESGold is advancing a major exploration campaign. Montauban has never undergone systematic modern exploration.

The company is currently completing a large-scale Ambient Noise Tomography (ANT) survey—a powerful 3D imaging technology that will define the size, shape, and continuity of the mineralized system. ANT is already showing strong results, with imaging going beyond the original 400m depth target and now expected to exceed 800m. This cutting-edge technology has the potential to reveal the full extent of the anomaly for the first time in Montauban’s 110-year history.

Scalable, Replicable, Clean Mining

Montauban is also part of a broader vision. Across Canada and globally, there are hundreds of orphaned or legacy mine sites that remain unrehabilitated despite containing valuable residual metals in tailings. Quebec alone is home to more than 259 of these sites, highlighting the scale of the opportunity. ESGold is advancing a scalable and replicable clean extraction model that transforms legacy sites into productive assets while setting a new benchmark for sustainable resource recovery.

The company has also performed testing that utilizes Dundee Sustainable Technologies’ CLEVR Process™, a proprietary non-cyanide extraction method that achieved 90.9% gold recovery in lab testing. This clean processing approach remains a valuable and scalable asset supporting ESGold’s near-term production and exploration growth strategy.

As a complement to its core mining operations, ESGold is developing clean technology solutions through a joint venture with DMCMS Inc. This initiative includes a polymer division that manufactures environmentally friendly products such as road stabilizers, dust suppressants, and other industrial blends—expanding the company’s sustainable commercial footprint.

Market Opportunity

ESGold is operating in a unique and specialized segment of the mining industry—reprocessing and revitalizing legacy mine sites. The Montauban Project offers both near-term cash flow and long-term growth potential by converting tailings into revenue while systematically exploring for additional high-value mineral endowments. The company’s established infrastructure, full permitting, and reclamation approvals reduce development risk and enhance execution timelines.

The broader green mining market is projected to reach $15.92 billion by 2030, according to Grand View Research. This growth is being driven by increased demand for responsible extraction methods, ESG-aligned practices, and critical mineral security. With construction underway at its fully permitted Montauban site—and exploration advancing along a Broken Hill-type geological model—ESGold is well positioned to emerge as Canada’s next premier gold and silver producer.

Leadership Team

Paul Mastantuono, Chief Executive Officer and Director, graduated with distinction from the University of Ottawa with a bachelor’s degree in social science, concentrating in criminology. He has extensive experience in the construction and transportation industries and has worked as an independent business consultant for various companies, including DNA Precious Metals Inc.

Brad Kitchen, President and Director, brings over 35 years of experience in investment banking and senior corporate management, primarily with resource-based companies. He has a detailed knowledge of regulatory, security, and tax issues, cross-border financings, and market influences, which he has applied to address business challenges for issuers and investors. Mr. Kitchen was also CEO of Eagle Hill Exploration, the company that generated in only five years the first Bankable Feasibility Study on the Windfall Lake Gold Project that was recently sold by Osisko Mining to Gold Fields for US$1.6 billion.

Andre Gautier, Senior Geologist and Director, brings over 47 years of experience in the Mining Exploration field and has worked in over 35 countries. His work experience includes entities such as: SOQUEM, Falconbridge Ltd., Noramco and Cambior Inc. Mr. Gauthier was president of MaxyGold Corp. (China), INCA Pacific Resources Inc., Lara Exploration Ltd., and Gold Holding Ltd. Mr. Gauthier also served as a Director of Vena Resources Inc., MaxyGold Corp., Lara Exploration Ltd., Western Union Peru, and Gold Holding Ltd., and from March 2015 until 2018, he served as interim Managing Director and CEO of Gold Holding Ltd., headquartered in Dubai (UAE). He has a BSC in Geology Eng. and MSC from UQAC (Chicoutimi, Quebec) and is an active member and leader of many mining and professional organizations (Canada, Peru, UAE, and China).

ESGold Corp. (OTCQB: ESAUF), closed Tuesday's trading session at $0.3785, off by 0.3947369%, on 107,195 volume. The average volume for the last 3 months is 223,360 and the stock's 52-week low/high is $0.31/$1.1.

Recent News

• ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) - MiningNewsBreaks - ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Featured in IBN MiningNewsWire Podcast Interview
• MiningNewsBreaks - ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) to Drill Historic Heap Leach Pads At Santa Fe Project
• ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Nears Drill Program Start as Part of Multi-Pronged Gold Revenue Strategy